Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update
- PMID: 23351992
- PMCID: PMC5693339
- DOI: 10.1016/j.hoc.2012.10.003
Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update
Abstract
Shwachman-Diamond syndrome (SDS) is an inherited neutropenia syndrome associated with a significant risk of aplastic anemia and malignant transformation. Multiple additional organ systems, including the pancreas, liver, and skeletal and central nervous systems, are affected. Mutations in the Shwachman-Bodian-Diamond syndrome (SBDS) gene are present in most patients. There is growing evidence that SBDS functions in ribosomal biogenesis and other cellular processes. This article summarizes the clinical phenotype of SDS, diagnostic and treatment approaches, and novel advances in our understanding of the molecular pathophysiology of this disease.
Copyright © 2013 Elsevier Inc. All rights reserved.
References
-
- Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature. 2010;464(7290):852–7. http://dx.doi.org/10.1038/nature08851. - DOI - PMC - PubMed
-
- Nihrane A, Sezgin G, Dsilva S, et al. Depletion of the Shwachman-Diamond syndrome gene product, SBDS, leads to growth inhibition and increased expression of OPG and VEGF-A. Blood Cells Mol Dis. 2009;42(1):85–91. - PubMed
-
- Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 2003;33(1):97–101. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical